glp-1 microdosing benefits THE PCCA BLOG Why Are Fit Guys Microdosing

The Tirzepatide (Zepbound) segment is expected to grow at the fastest rate during the forecast period due to its dual-action mechanism, targeting both GLP-1 and GIP receptors, which enhances weight loss outcomes

10 or 15 mg once weekly) vs Reduce to tirzepatide 5 mg once weekly vs Placebo for 52 weeks (randomized 3:3:2 at week 60) Primary outcome: Percent change in bodyweight from baseline to week 112 Results: Primary outcome (percent change in bodyweight at week 112): Tirzepatide MTD -21.9%, Tirzepatide 5 mg -16.6%, Placebo -9.9% (estimated treatment difference vs placebo -12.0% for MTD and -6.6% for 5 mg

[DOI] [PubMed] [Google Scholar] 61.Rggeberg A., Meybohm P., Nickel E.A

It acquired One Medical in 2023 for $3.9 billion

Structured fitness programs, evidence-based nutrition coaching, and whole-person wellness support create the conditions where every other intervention works better and lasts longer